Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Debt Ratio (2016 - 2026)

Ocular Therapeutix has reported Debt Ratio over the past 14 years, most recently at 0.1 for Q1 2026.

  • For Q1 2026, Debt Ratio fell 42.3% year-over-year to 0.1; the TTM value through Mar 2026 reached 0.1, down 42.3%, while the annual FY2025 figure was 0.09, 40.99% down from the prior year.
  • Debt Ratio for Q1 2026 was 0.1 at Ocular Therapeutix, up from 0.09 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.4 in Q3 2023 and troughed at 0.09 in Q4 2025.
  • A 5-year average of 0.17 and a median of 0.15 in 2025 define the central range for Debt Ratio.
  • Biggest five-year swings in Debt Ratio: skyrocketed 152.45% in 2023 and later plummeted 65.52% in 2024.
  • Year by year, Debt Ratio stood at 0.17 in 2022, then soared by 54.27% to 0.26 in 2023, then tumbled by 42.68% to 0.15 in 2024, then tumbled by 40.99% to 0.09 in 2025, then increased by 11.43% to 0.1 in 2026.
  • Business Quant data shows Debt Ratio for OCUL at 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.17 in Q3 2025.